Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 11.99% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
McEwen Inc
MUX
$1.14B
| $88K | ﹤0.01% |
19,928
-21
| -0.1% | -$131 |
|
4077
Rezolute
RZLT
$443M
| $88K | ﹤0.01% |
+27,251
| New | +$90.6K |
|
4078
CALL
Carnival Corporation Ltd
CCL
$38.9B
| $87K | ﹤0.01% |
+10,000
| New | +$147K |
|
|
HYPD
4079
Hyperion DeFi Inc
HYPD
$42.9M
| $87K | ﹤0.01% |
558
-12
| -2% | -$2.19K |
|
4080
Nu Holdings
NU
$67.3B
| $86K | ﹤0.01% |
+22,940
| New | +$116K |
|
4081
Omeros
OMER
$1.26B
| $86K | ﹤0.01% |
31,175
-173,985
| -85% | -$590K |
|
|
CBAY
4082
DELISTED
Cymabay Therapeutics
CBAY
| $86K | ﹤0.01% |
29,136
-247,630
| -89% | -$592K |
|
4083
Pliant Therapeutics
PLRX
$66.9M
| $85K | ﹤0.01% |
10,570
-62,729
| -86% | -$402K |
|
4084
Redwire
RDW
$3.3B
| $85K | ﹤0.01% |
+28,125
| New | +$135K |
|
|
AIOT
4085
PowerFleet Inc
AIOT
$421M
| $85K | ﹤0.01% |
39,468
-2,306
| -6% | -$5.86K |
|
|
ADVM
4086
DELISTED
Adverum Biotechnologies
ADVM
| $84K | ﹤0.01% |
6,971
-25,348
| -78% | -$266K |
|
|
ONCR
4087
DELISTED
Oncorus, Inc.
ONCR
| $84K | ﹤0.01% |
67,025
-55,022
| -45% | -$74.7K |
|
|
GATO
4088
DELISTED
Gatos Silver, Inc.
GATO
| $83K | ﹤0.01% |
28,952
-140,547
| -83% | -$494K |
|
4089
OppFi
OPFI
$608M
| $82K | ﹤0.01% |
+25,125
| New | +$81K |
|
|
UPH
4090
DELISTED
UpHealth, Inc.
UPH
| $82K | ﹤0.01% |
13,858
-894
| -6% | -$6.96K |
|
4091
Standard BioTools
LAB
$294M
| $81K | ﹤0.01% |
50,644
-229,542
| -82% | -$568K |
|
4092
Stereotaxis
STXS
$137M
| $81K | ﹤0.01% |
44,229
-112,490
| -72% | -$269K |
|
4093
Ultralife
ULBI
$124M
| $81K | ﹤0.01% |
17,782
| – | – |
|
|
AVCT
4094
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
| $81K | ﹤0.01% |
21,406
-38
| -0.2% | -$302 |
|
|
CEMI
4095
DELISTED
Chembio diagnostics, Inc.
CEMI
| $81K | ﹤0.01% |
123,952
-798
| -0.6% | -$530 |
|
4096
American Resources Corp
AREC
$302M
| $80K | ﹤0.01% |
55,080
+25,825
| +88% | +$46K |
|
4097
Microbot Medical
MBOT
$113M
| $80K | ﹤0.01% |
15,508
-102
| -0.7% | -$568 |
|
|
AGIL
4098
DELISTED
AgileThought Inc
AGIL
| $80K | ﹤0.01% |
+15,458
| New | +$73.1K |
|
4099
Wave Life Sciences
WVE
$1.02B
| $79K | ﹤0.01% |
24,168
-102,942
| -81% | -$198K |
|
|
PVLA
4100
Palvella Therapeutics
PVLA
$2.26B
| $79K | ﹤0.01% |
524
+25
| +5% | +$4.56K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.